Masimo (MASI): Reassessing Valuation After a Steady Slide in Share Price

Simply Wall St.12-20 10:17

Masimo (MASI) has been drifting lower recently, and that slide is catching investors attention as they reassess what the current price implies about the company future earnings power and competitive ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2592111556?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163","is_english":true,"pubTime":"2025-12-20 10:17","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2592111556","market":"sg","top_or_hot":-1,"title":"Masimo (MASI): Reassessing Valuation After a Steady Slide in Share Price","media":"Simply Wall St.","content":"<div>\n<p>Masimo (MASI) has been drifting lower recently, and that slide is catching investors attention as they reassess what the current price implies about the company future earnings power and competitive ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-masi/masimo/news/masimo-masi-reassessing-valuation-after-a-steady-slide-in-sh\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Masimo (MASI): Reassessing Valuation After a Steady Slide in Share Price</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMasimo (MASI): Reassessing Valuation After a Steady Slide in Share Price\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-12-20 10:17 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nasdaq-masi/masimo/news/masimo-masi-reassessing-valuation-after-a-steady-slide-in-sh><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Masimo (MASI) has been drifting lower recently, and that slide is catching investors attention as they reassess what the current price implies about the company future earnings power and competitive ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-masi/masimo/news/masimo-masi-reassessing-valuation-after-a-steady-slide-in-sh\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MASI","symbol_name":"麦斯莫医疗","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-masi/masimo/news/masimo-masi-reassessing-valuation-after-a-steady-slide-in-sh","article_id":"2592111556","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-masi/masimo/news/masimo-masi-reassessing-valuation-after-a-steady-slide-in-sh","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2592111556","pubTimestamp":1766197076,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Masimo (MASI) has been drifting lower recently, and that slide is catching investors attention as they reassess what the current price implies about the company future earnings power and competitive position.\nSee our latest analysis for Masimo.\nThe latest dip comes on top of a much steeper slide, with the share price down around 20 percent year to date and the one year total shareholder return similarly weak. This signals that momentum has clearly been fading as investors reassess growth and...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"MASI":"麦斯莫医疗","BK4082":"医疗保健设备","LU2764263039.SGD":"BGF GLOBAL UNCONSTRAINED EQUITY \"A2\" (SGDHDG) ACC","LU0205194284.USD":"SCHRODER ISF US SMALL & MID-CAP EQUITY \"A\" (USD) INC AV","LU0240877869.USD":"SCHRODER ISF GLOBAL SMALL COMPANIES \"A\" ACC","LU2764263203.CNY":"BGF GLOBAL UNCONSTRAINED EQUITY \"A2\" (CNYHDG) ACC","LU0205193047.USD":"SCHRODER ISF US SMALL & MID-CAP EQUITY \"A\" (USD)  ACC","LU0240878834.USD":"SCHRODER ISF GLOBAL SMALL COMPANIES \"A\" (USD) INC AV","LU2720916845.USD":"BGF GLOBAL UNCONSTRAINED EQUITY \"A2\" (USD) ACC","LU2764262908.HKD":"BGF GLOBAL UNCONSTRAINED EQUITY \"A2\" (HKD) ACC","DCF":"Dreyfus Alcentra Global Credit Income 2024 Target Term Fund, Inc"},"translate_title":"Masimo(MASI)：股价稳步下滑后重新评估估值","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DCF":1,"MASI":1.5},"content_text":"Masimo (MASI) has been drifting lower recently, and that slide is catching investors attention as they reassess what the current price implies about the company future earnings power and competitive position. See our latest analysis for Masimo. The latest dip comes on top of a much steeper slide, with the share price down around 20 percent year to date and the one year total shareholder return similarly weak. This signals that momentum has clearly been fading as investors reassess growth and risk. If Masimo recent pullback has you rethinking your sector exposure, this could be a good moment to explore other healthcare stocks that might offer a different balance of growth and resilience. With the share price lagging and analysts still seeing upside to their targets, the key question now is whether Masimo is quietly undervalued or if the market is already discounting any meaningful recovery in growth. Most Popular Narrative Narrative: 26.8% Undervalued Compared to Masimo last close at $134.04, the most widely followed narrative pegs fair value much higher, implying sizable upside if its assumptions play out.  Ongoing innovation including next-gen monitors featuring advanced AI algorithms and redeployment of novel sensor technologies positions Masimo to command premium pricing and capture greater value as hospitals prioritize technologically advanced, multiparameter solutions, supporting both revenue expansion and improved gross margins.  Read the complete narrative. Curious how falling headline revenues can still line up with a higher valuation. The story hinges on a sharp margin reset and a rich future earnings multiple. Want to see how those moving parts combine into that fair value call. Result: Fair Value of $183.13 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, that upbeat narrative could unravel if tariffs escalate or hospital capital budgets stay tight, delaying equipment upgrades and pressuring Masimo revenue trajectory. Find out about the key risks to this Masimo narrative. Another View on Value While the popular narrative sees Masimo as 26.8 percent undervalued, our DCF model tells a very different story. On those cash flow assumptions, fair value sits nearer $98.04, meaning today price looks stretched rather than cheap. Which set of expectations do you trust more? Look into how the SWS DCF model arrives at its fair value. MASI Discounted Cash Flow as at Dec 2025Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Masimo for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 914 undervalued stocks based on their cash flows. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.  Build Your Own Masimo Narrative If you see the story differently or want to dig into the numbers yourself, you can build a custom view in minutes: Do it your way. A good starting point is our analysis highlighting 2 key rewards investors are optimistic about regarding Masimo. Looking for more investment ideas? Before you move on, put Simply Wall Street to work for you and lock in a watchlist of fresh opportunities that most investors are still overlooking.  Capitalize on overlooked value by scanning these 914 undervalued stocks based on cash flows that strong cash flows suggest the market is mispricing right now. Ride powerful structural trends by targeting these 29 healthcare AI stocks bringing data driven breakthroughs to hospitals, diagnostics, and treatment pathways. Position yourself at the edge of financial innovation with these 79 cryptocurrency and blockchain stocks shaping the future of payments, security, and decentralized infrastructure.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.Mobile Infrastructure for Defense and DisasterThe next wave in robotics isn't humanoid. Its fully autonomous towers delivering 5G, ISR, and radar in under 30 minutes, anywhere.Get the investor briefing before the next round of contractsSponsored On Behalf of CiTechNew: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2592111556","isCrawlerRequest":true}